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ABSTRACT
Objective: To compare pregnancy rates with fresh and frozen embryo transfer in patients admitted to Royal Jubilee Maternity 
Service  (RJMS),  Belfast  between  January  1st  2004  and  December  31st  2005  with  ovarian  hyperstimulation  syndrome 
(OHSS).
Method: A retrospective analysis of all ART cycles (2,283) carried out in RJMS between January 1st 2004 and December 31st 
2005 and of all patients admitted to RJMS within 3 weeks of assisted reproduction therapy (ART). 
Results: The incidence of OHSS requiring admission was 2.01%, which represented 80.70% of post-ART emergency admissions. 
The eventual pregnancy rate was 52.27% in all women admitted with OHSS.  The pregnancy outcome in OHSS patients who 
received fresh embryo transfer was 56.52% and with frozen embryo transfer 50%.  The main indications for fertility treatment 
in OHSS cases were male factor (31%) and polycystic ovarian syndrome (14%).  Two distinct incidence peaks of OHSS were 
identified – early and late.  77.77% of women who suffered from late onset OHSS had a concurrent positive pregnancy test.  
Conclusion: The pregnancy rate in OHSS cases, both with fresh and subsequently with frozen embryo transfer, was exceptionally 
high.  There was no statistically significant difference between fresh and frozen embryo transfer pregnancy rates.  An elective 
embryo freezing policy to moderate the severity and duration of OHSS does not compromise outcome for women at risk of 
OHSS.
INTRODUCTION
OHSS is a major complication of fertility treatment occurring 
in between 0.6% and 10% of ovarian stimulation cycles for 
assisted reproduction (ART)1. Whilst the primary aetiological 
factor is a largely unpredictable and excessive response to 
follicle stimulating hormone (FSH), in fact, the syndrome 
will not occur without the administration of human chorionic 
gonadotrophin  (hCG)  either  exogenously,  to  induce  the 
final maturation of the follicle prior to oocyte retrieval, or 
endogenously, from an establishing pregnancy2.  
The exact pathogenesis of OHSS is still not fully understood 
but  the  involvement  of  cytokines,  particularly  vascular 
endothelial growth factor (VEGF), and the ovarian renin-
angiotensin  system  (RAS)  are  clearly  central  to  the 
pathogenesis of the condition2,3.
Clinically, OHSS results in ovarian enlargement and a shift of 
protein-rich fluid from the vascular compartment into the third 
space compartments (particularly the peritoneal and pleural 
cavities), leading to the potentially fatal complications of 
renal failure, through hypoperfusion, and thromboembolism 
by haemoconcentration and increased viscosity4,5.  
A variety of approaches has been taken to help prevent OHSS 
including “coasting” whilst on treatment (the suspension of 
FSH stimulation to allow the ovarian response to quieten) 
and, once the oocytes have been retrieved, the freezing of all 
embryos for transfer subsequent to the ovaries quietening 
down: the condition is clearly aggravated and prolonged by 
both the degree of ovarian stimulation and by pregnancy1,2.  
In  the  Regional  Fertility  Centre  (RFC),  Royal  Jubilee 
Maternity Service (RJMS), Belfast there is an active policy of 
freezing all embryos if the patient is deemed clinically to be at 
high risk of developing OHSS. The definition of “high risk” 
is arbitrary and includes the number of oocytes obtained, the 
amount of ascites and the size of the ovaries at oocyte retrieval 
as well as the age of the patient and any previous history of 
OHSS. However, as the prediction of OHSS is imprecise, a 
significant number of cases will still occur in patients who 
have undergone fresh embryo transfer. As a result, there tend 
to be two peaks of incidence of OHSS: the first occurs within 
a week of the ovulatory hCG injection whilst the second 
occurs in response to pregnancy, typically around two weeks 
after the injection.© The Ulster Medical Society, 2008.
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It has been postulated that as OHSS occurs in those women 
with the most florid response to stimulation, their pregnancy 
rates should be significantly greater than the overall pregnancy 
rates for both fresh (24%) and frozen embryo transfer (22%) 
in  any  one  unit.  In  this  study  fresh  and  frozen  embryo 
transfer pregnancy rates will be determined for patients who 
developed OHSS and compared with pregnancy rates in the 
unit as a whole.
MATERIALS AND METHODS
Charts were reviewed for all women admitted to RJMS with 
a diagnosis of OHSS after ART between January 1st 2004 
and December 31st 2005 at the RFC, Belfast. In all 2,283 
ART cycles were performed and 57 charts were identified 
for women subsequently admitted to RJMS with OHSS. As 
the RFC serves the geographically small region of N. Ireland, 
all patients are advised to attend RJMS if they have any 
complication of treatment. It is the experience of the unit that 
patients are very infrequently admitted elsewhere with OHSS 
arising from treatment in the RFC. 
The  following  information  was  recorded:  the  woman’s 
previous medical history; the primary indication for ART; 
the date of oocyte retrieval; the date of embryo transfer and 
whether this was with fresh or frozen embryos; the date of 
presentation with OHSS and the management. Pregnancy 
outcomes were also noted.  
All patients had previously given written consent to allow 
their charts to be audited. 
RESULTS
A  total  of  1,123  fertility  treatments  were  carried  out  in 
2004 and 1,160 in 2005.  The distribution between in-vitro 
fertilisation (IVF), intra-cytoplasmic sperm injection (ICSI), 
and frozen embryo transfer (FET) is given in Table I. 
In 2004, there were 29 (2.58%) emergency admissions to 
RJMS following fertility treatment whilst in 2005 there were 
28 (2.41%) emergency admissions.  In total, therefore, for 
the two years, 52 patients were admitted with 57 admissions 
(5 patients were admitted on two separate occasions).  Of 
these 57 admissions, 46 (80.70%) were due to OHSS - two 
patients were admitted twice with OHSS.  Of the remaining 
11 admissions: 5 were due to an ovarian cyst; 2 to an ovarian 
abscess; 2 to miscarriage; 1 to an ectopic pregnancy; and 1 to 
unspecified abdominal pain.    
The primary indications for ART for the 44 patients admitted 
with OHSS are compared with the primary indications for 
treatment  amongst  the  general  population  of  N.  Ireland 
attending the RFC in Table II.
The degree of OHSS was classified as moderate in 37 (80%) 
and severe in 9 (20%) cases (OHSS Classification, National 
Collaborating Centre for Women’s and Children’s Health)1. 
Where  the  OHSS  was  classified  as  mild  it  was  routinely 
managed as an outpatient and, therefore, not identified in this 
study. Of the 44 patients admitted with OHSS, 3 experienced 
severe complications: one deep vein thrombosis (DVT) and 
two pleural effusions.  
Of the 44 patients admitted, 23 (52%) had undergone fresh 
embryo transfer, whilst 20 (45%) had had all their embryos 
frozen.  Two patients had fertilisation failure and, therefore, 
no embryo transfer from the stimulation cycle. One patient 
had two separate frozen embryo transfer cycles in the year 
2005. Of the 23 patients who had a fresh embryo transfer, 
17 (74%) became pregnant of whom 13 (76.5%) went on to 
give birth (10 singletons and 3 twin pregnancies). Of the 20 
frozen embryo transfers, 12 (60%) patients became pregnant 
of whom 10 (83%) went on to give birth (8 singletons and 2 
twin pregnancies). 
Overall, for all patients admitted with OHSS, 29 conceived 
of whom 6 (21%) miscarried, 18 (62%) had a singleton live 
birth and 5 (17%) had twins. This demonstrated a positive 
pregnancy outcome in patients who were admitted with OHSS 
of 52.27% overall – 56.52% with fresh embryo transfer and 
50% with frozen embryo transfer.  This difference was not 
statistically significant (χ2=0.183, dof=1, p>0.2).   
Amongst  the  23  patients  admitted  as  an  emergency  for 
OHSS who received fresh embryo transfers, only one patient 
was admitted twice due to OHSS – an early admission and 
a  late  admission. The  majority,  13  (57%),  were  admitted 
early and 9 (39%) were admitted late. Of those women who 
Ta b l e  II. 
Comparison of primary indication for treatment in those 
undergoing ART in the RFC vs OHSS patients
Indication for 
treatment:
General 
Population in 
N. Ireland:
OHSS 
Group:
% 
Difference:
Male Factor 43.86% 31% - 12.86%
Unexplained 19.02% 25% + 5.98%
Tubal Disease 14.34% 14% - 0.34%
Multiple 
Factors
8.02% 0% - 8.02%
Ovulatory 
Disorder
7.24% 14% + 6.76%
Endometriosis 4.03% 11% + 6.97%
Multiple 
Female Factors
3.2% 0% - 3.2%
Other 0.27% 5% + 4.73%
Ta b l e  I: 
The overall number of ARTs undertaken in 2004 and 2005.
Fertility Treatment: 2004: 2005: TOTAL:
IVF 484 515 999
ICSI 405 412 817
FET 234 233 467
TOTAL: 1123 1160 2283© The Ulster Medical Society, 2008.
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were admitted with early OHSS, 6 (46.15%) had a positive 
pregnancy outcome and of those with late OHSS, 7 (77.77%) 
had a positive pregnancy outcome. Early OHSS was defined 
as patients who presented within 9 days of oocyte retrieval 
and late OHSS was defined as patients who presented 10 or 
more days following oocyte retrieval.
DISCUSSION
In this study the incidence of complications arising from 
ART in the RFC, Belfast necessitating admission between 
January 1st 2004 and 31st December 2005 was 2.5%.  This 
is in keeping with national figures of between 2.04% and 
15%4,6,7. Of these 57 admissions, 46 (80.70%) were due 
to OHSS, which represented an incidence of 2.01%. This 
again was in keeping with the published incidence rates for 
OHSS of between 0.6% and 10%6,8. 
Within the patient population admitted for OHSS, the main 
indication for ART was male factor infertility (31%), with 
unexplained  infertility  representing  25%  and  PCOS  only 
14% of cases. This distribution contrasts with the literature, 
where PCOS is the commonest indication for ART in OHSS 
patients9. A study by Abramov, Elchalal, and Schenker in 
1998  reported  that  35.6%  of  those  admitted  with  OHSS 
and receiving fertility treatment had anovulatory infertility, 
while 23.3% had male factor infertility and only 8% had 
unexplained infertility10. Within this unit overall, the major 
indication  for ART  was  male  factor  infertility  whilst  the 
indication  was  PCOS  in  only  7.24%  of  ART  patients. 
However, a 14% incidence of PCOS in OHSS patients is twice 
that in the ART population at large in N. Ireland suggesting 
that PCOS predisposes to this condition.
In the Regional Fertility Centre, Belfast there is an active but 
arbitrary policy of deferring embryo transfer and performing 
embryo freezing if a woman is deemed to be at significant risk 
of OHSS. Clearly, the unit’s policy does not result in a reduced 
pregnancy rate per oocyte retrieval. However, the significantly 
small number of OHSS patients with elective embryo freezing 
highlights the importance of this approach.    
The pregnancy rates reported in this study were significantly 
greater  than  those  reported  by  the  National  Institute  of 
Clinical  Excellence  (NICE),  which  suggested  an  average 
live birth rate per fresh embryo transfer of 17.6% based on 
figures from January 1995 to March 19991. In comparison, 
NICE found that the average live birth rate per frozen embryo 
transfer was 11.5% based on national figures from January 
1995  to  March  19991.  OHSS  patients  are  by  definition 
patients whose ovaries respond excessively to gonadotrophin 
stimulation. Therefore, these women should have an increased 
chance of oocyte production and an increased number of 
Ta b l e  3: 
Total Number of Admissions to the RJMS following ART, Fresh vs Frozen Embryo Transfers for OHSS Patients, and the 
Pregnancy Outcome
Total Admissions 2004-2005:
52 Patients (57 Admissions)
Admissions due to OHSS: 46 (44 Patients) Admissions due to other conditions: 11
Fresh Embryo Transfers: 23
Frozen Embryo Transfers: 20 (1 
Patient had 2 FET)
Fertilisation Failure: 2 
Failed Pregnancy: 8  Positive Pregnancy: 12  Failed pregnancy: 6  Positive Pregnancy: 17 
Live Births: 13 Patients Live Births: 10 Patients© The Ulster Medical Society, 2008.
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oocytes compared to other women and, consequently, it is 
not unreasonable that they would have an increased chance 
of successful fertilisation and pregnancy.  
In  addition  to  various  degrees  of  severity  of  OHSS, 
patients that received a fresh embryo transfer are at risk of 
experiencing both an early and a late occurrence of OHSS. 
Early  onset  OHSS  is  thought  to  be  due  primarily  to  the 
administration of exogenous hCG whilst late onset OHSS is 
induced primarily by endogenous hCG from the implanting 
embryo8,11. To support the theory that late OHSS results from 
endogenously produced hCG from the implanting embryo and 
that it confers a better pregnancy outcome, our study found 
that 77.77% of the women who suffered from late OHSS 
had a positive pregnancy outcome. That is over 60% higher 
than the average birth rates following fresh embryo transfer 
and over 50% higher than the overall birth rates amongst our 
unit’s general patient population. A study by Papanikolaou et 
al in 2006 found that all patients with severe OHSS became 
pregnant; a study by Abramov, Elchalal, and Schenker in 1998 
found that 73% of women with severe OHSS had positive 
pregnancy  outcomes;  and  Schenker  in  1999  described  a 
clinical  pregnancy  rate  of  73.2%  in  women  with  severe 
OHSS8,10,12. 
Our  results,  in  conjunction  with  the  published  literature, 
appear  to  support  strongly  the  assumption  that  OHSS  is 
predictive of a successful outcome and that an active policy 
of embryo freezing and deferment of embryo transfer is not 
disadvantageous to the patient in terms of pregnancy.     
CONCLUSION
OHSS  represented  80.70%  of  emergency  admissions 
following ART. This remains both a major burden on hospital 
services and a significant risk to patients. OHSS in its severe 
form is potentially fatal. However, OHSS is an indicator of 
high  fertility  with  an  ultimate  pregnancy  rate  of  52.27% 
in those who develop OHSS. This compares to an average 
pregnancy rate of 11.5% - 17.6% in the ART population 
nationally.   
In conclusion, it is essential to counsel patients about the 
risks  of  OHSS  prior  to  initiating  fertility  treatment.  It  is 
always disappointing to be told that embryo transfer is not 
to take place as planned in order to prevent OHSS. However, 
significant comfort may be derived from the excellent frozen 
embryo transfer pregnancy rates in this unit.  
The authors have no conflict of interest.
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